Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Go back to Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain| (NASDAQ: ACON) | Delayed: 3.12 -0.09 (2.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $ | |||
| Open | $3.17 | 52 Week Low | $ | |||
| Day High | $3.30 | P/E | N/A | |||
| Day Low | $3.12 | EPS | $ | |||
| Volume | 25,228 | |||||
| (NASDAQ: ACONW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 11,345 | |||||
